Editorial Scope
Aims and Scope
Areas of scientific inquiry and clinical practice welcomed by the journal
Journal Aims
The International Journal of Pharmacology, Pharmacotherapeutics and Therapy provides an international, scholarly platform for researchers, clinical pharmacologists, pharmacists, and medical practitioners to publish original research and critical reviews addressing the mechanisms, applications, and therapeutic outcomes of medicines in human health and disease.
We aim to foster translational dialogue: advancing basic pharmacological discoveries into safe, personalized, and cost-effective clinical therapies.
Subject Scope & Key Disciplines
1. Clinical Pharmacology & Pharmacokinetics
- Preclinical and clinical pharmacokinetics (PK) & pharmacodynamics (PD)
- Pharmacogenomics, personalized medicine, and biomarker-guided therapy
- Therapeutic drug monitoring (TDM) and dosing optimization
- Drug-drug and drug-nutrient interactions
- Pediatric, geriatric, and special population clinical pharmacology
2. Medical Pharmacotherapeutics
- Cardiovascular and renal therapeutics
- Antimicrobial stewardship and infectious disease therapy
- Oncology and targeted immunotherapies
- Neuropharmacology and psychiatric therapeutics
- Endocrinology, diabetes, and metabolic disorders
3. Clinical Pharmacy & Pharmacy Practice
- Hospital, community, and ambulatory pharmacy practice
- Medication reconciliation and clinical pharmacy interventions
- Rational drug use and formulary management
- Patient counseling and medication adherence research
- Pharmacoepidemiology and pharmacoeconomic evaluations
4. Drug Safety, Toxicology & Pharmacovigilance
- Adverse drug reactions (ADR) detection and surveillance
- Post-marketing safety studies and regulatory pharmacovigilance
- Clinical toxicology, poisoning, and overdose management
- Medication error analysis and patient safety protocols
Accepted Article Categories
Original Research Articles:Full reports of original, hypothesis-driven basic, translational, or clinical investigations. (Up to 4,500 words, structured abstract).
Systematic Reviews & Meta-Analyses:Rigorous syntheses of evidence conducted in compliance with PRISMA guidelines. (Up to 5,500 words).
Narrative Reviews:Comprehensive overviews of emerging drug classes or therapeutic controversies. (Up to 5,000 words).
Clinical Case Reports:Well-documented, instructive clinical cases highlighting novel adverse reactions, unexpected interactions, or unique therapeutic challenges. Compliant with CARE guidelines. (Up to 2,000 words).
Brief Communications & Letters:Preliminary findings of high scientific interest or constructive scholarly commentary on recently published work. (Up to 1,500 words).
Out of Scope Criteria
The journal strictly excludes:
- Uncharacterized crude herbal extract studies lacking phytochemically standardized active constituents.
- In silico molecular docking studies lacking biological or experimental validation.
- Routine hospital audits lacking generalizable clinical or scientific insight.
- Manuscripts previously published or under consideration elsewhere.
